Receptor - Based Drug Design Editor(s):Paul Leff

Special Indian Reprint !

Receptor - Based Drug Design

Editor(s):

Paul Leff

Series:

Drugs and the Pharmaceutical Sciences

Published:

April 10, 1998 by CRC Press

Content:

400 Pages

Summary

Employing a wide range of examples from G-protein-coupled receptors and ligand-gated ion channels, this detailed, single-source reference illustrates the principles of pharmacological analysis and receptor classification that are the basis of rational drug design.
Explains the experimental and theoretical methods used to characterize interactions between ligands and receptors-providing the pharmacological information needed to solve treatment problems and facilitate the drug design process!
Demonstrating the achievements of the receptor-based approach in therapeutics and indicating future directions, Receptor-Based Drug Design

introduces novel computer-assisted strategies for the design of new agonists, antagonists, and inverse agonists for G-protein-coupled receptors

shows how to assess agonist concentration-effect curve data

discusses radioligand binding assays

presents new in vitro multiarray assays for G-protein-coupled receptors

explains the use of individual second messenger signaling responses in analyzing drug-receptor interactions

examines the role of electrophysiology in finding new drugs and drug targets

describes selectively acting b-adrenoceptor agonists and glucocorticoid steroids for asthma treatment

outlines the rationale for using angiotensin receptor antagonists

and more!
Written by over 25 international authorities and containing nearly 1200 bibliographic citations, Receptor-Based Drug Design is a practical resource for pharmacologists, pharmacists, and pharmaceutical scientists; organic and medicinal chemists and biochemists; molecular biologists; biomedical researchers; and upper-level undergraduate and graduate students in these disciplines.

Introduction, James Black

Principles and Measurement of Drug-Receptor Interactions

The Characterization and Classification of Receptors, Patrick P. A. Humphrey
Functional Methods for Quantifying Agonists and Antagonists, Iain G. Dougall
Quantification of Receptor Interactions Using Binding Methods, Sebastian Lazareno
Drug Analysis Based on Signaling Responses to G-Protein-Coupled Receptors, T. Kendall Harden, José L. Boyer, and Robert W. Dougherty
The Use of Electrophysiology to Improve Understanding of Drug-Receptor Interactions, John G. Connolly and Charles Kennedy

Receptor-Based Drugs in Medicine

Selective Adrenergic and Glucocorticoid Treatments for Asthma, David Jack
Serotonin 5-HT1B/D Receptor Agonists, Graeme R. Martin
Histamine H2-Receptor Antagonists, Michael E. Parsons
Angiotensin Antagonists, Mark J. Robertson

Experimental and Emerging Drugs

-Adrenoceptor Agonists and Antagonists, J. Paul Hieble and Robert R. Ruffolo, Jr.
P2U-Purinoceptor Agonists: Emerging Therapy for Pulmonary Diseases, Eduardo R. Lazarowski, William C. Watt, T. Kendall Harden, and Richard C. Boucher
Muscarinic Receptor Antagonists Pharmacological and Therapeutic Utility, Richard M. Eglen
NMDA Receptor Antagonists, John A. Kemp and James N. C. Kew

New Trends in Drug Design

Computational Chemistry in Receptor-Based Drug Design, Ad P. IJzerman, Eleonora M. van der Wenden, and Wilma Kuipers
Recombinant G-Protein-Coupled Receptors as Screening Tools for Drug Discovery, A. Donny Strosberg and Prabhavathi B. Fernandes
Inverse Agonists and G-Protein-Coupled Receptors, Richard A. Bond and Michel Bouvier